SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immucor
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jodi Segal-Lankry who wrote (30)2/19/1998 10:42:00 PM
From: Thomas Kirwin  Read Replies (1) of 422
 
"It's Not A Question of If, It's When the ABS2000 Is Approved"

Jodi,

These powerful words were recently stated by an Immucor employee during a phone conversation. They truly believe in this gizmo!

I invested in BLUD some two years ago, made some chump change, lost patience and have returned to reap the Holy Grail. My gut tells me that it is just about time the device receives the a-ok from the FDA. Two years is a long time for a non-invasive testing instrument to be approved. Sure, I understand that ABS2000 relies on reagents to facilitate the matching process and the FDA wants to fully understand the pros and cons, but two years for approval is ridiculous. Don't forget that the ABS2000 is already being utilized in Canada and Europe. I believe that 25 are up and running without any problem.

The ABS2000 and reagents (AKA razor and blades) economic/profit model bode well for Immucor once approval is granted. They will have a lock on the blood instrument industry. The future sales opportunities will be endless.

I hope that this long winded response answers your query. Just in case let me make it perfectly clear that I personally expect approval very soon.

Regards,

Tom

P.S. The above is my opinion. Please perform your own do-diligence before investing.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News